Schedule 13D ownership disclosure

SIGILON THERAPEUTICS INC

Security class unavailable · CUSIP: 82657L107

Event date: 2023-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
40.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-183831
Form type
SC 13D
Filer
ELI LILLY & Co
CIK
CIK 59478
Filed
Jul 07, 2023
Reporting period
Jun 28, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub